Vtides Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.20 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Months 23 Days
- Open Charges ₹ 10.50 Cr
About Vtides Lifesciences
Vtides Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 2024 ( 11 months 23 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 3.20 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹10.50 Cr.
Rajashekar Mesineni, Enugala Reddy, and Vaishnavi Mesineni serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21000TS2024PTC182264
-
Company No.
182264
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Feb 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vtides Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajashekar Mesineni
|
Director | 16-Feb-2024 | Current |
|
Enugala Reddy
|
Director | 16-Feb-2024 | Current |
|
Vaishnavi Mesineni
|
Director | 16-Feb-2024 | Current |
Financial Performance of Vtides Lifesciences.
Enhance accessibility to Vtides Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vtides Lifesciences?
Unlock access to Vtides Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Venkar Chemicals Private LimitedRajashekar Mesineni and Enugala Reddy are mutual person
-
Progenerics Pharma Private LimitedRajashekar Mesineni is a mutual person
-
Venlar Labs Private LimitedRajashekar Mesineni and Enugala Reddy are mutual person
Charges (Loans)
₹10.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 10.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Oct 2024 | Others | ₹10.00 Cr | Open |
| 02 Oct 2024 | Others | ₹5.00 M | Open |
How Many Employees Work at Vtides Lifesciences?
Vtides Lifesciences has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vtides Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vtides Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.